Latest news
Grace Therapeutics (GRCE): Opaleye reports 2.75M-share, 13.07% ownership stake - Stock TitanStock Titan · Fri, 07 Aug 2026 20:06:08 GMTGRCE Stock On Track For Worst Week In 5.5 Years — What’s Driving The Selloff? - StocktwitsStocktwits · Fri, 07 Aug 2026 13:48:41 GMTGrace Therapeutics, Inc. Revenue Breakdown – NASDAQ:GRCE - TradingViewTradingView · Fri, 07 Aug 2026 12:57:52 GMTGrace Therapeutics Raises $10 Million in Private Placement, Grants Registration Rights - TradingViewTradingView · Thu, 06 Aug 2026 20:13:22 GMTGrace Therapeutics raises USD 10m to fund dual manufacturing strategy for GTx-104 NDA resubmission - AllSciAllSci · Wed, 05 Aug 2026 11:40:39 GMTGRCE Q1'26 Earnings: EPS estimate is (0.13) USD - TradingViewTradingView · Wed, 05 Aug 2026 11:01:59 GMTGrace Therapeutics Secures $10M Private Placement Agreement - Intellectia AIIntellectia AI · Wed, 05 Aug 2026 07:51:33 GMTGrace Therapeutics Expects Funding to Extend Cash Runway Through 2028 - Stock TitanStock Titan · Wed, 05 Aug 2026 03:43:14 GMT